| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $84.3M | -5.5% |
| R&D Expense | $13.2M | -32.7% |
| SG&A Expense | $230.1M | +221.1% |
| Operating Income | -$179.4M | -5720.6% |
| Pre-tax Income | -$171.4M | -2168.3% |
| Income Tax | -$80K | -127.8% |
| Net Income | -$171.3M | -2241.8% |
| EPS (Basic) | -$1.74 | -2275.0% |
| EPS (Diluted) | -$1.74 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.3M | -18.7% |
| Short-term Investments | $203.7M | -22.6% |
| Accounts Receivable | $25.3M | +210.1% |
| Inventory | $31.4M | +502.9% |
| Current Assets | $284.9M | -14.8% |
| Total Assets | $327.7M | -6.7% |
| Current Liabilities | $39.1M | +67.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$170.9M | -1361.2% |
| Capital Expenditures | $339K | -39.8% |
| Investing Cash Flow | $56.8M | +153.5% |
| Financing Cash Flow | $104.6M | +44.5% |
| Free Cash Flow | -$171.2M | -1418.5% |
| -2275.0% |
| Long-term Debt |
| $96.4M |
| — |
| Total Liabilities | $213.4M | +126.2% |
| Stockholders' Equity | $114.3M | -55.5% |